Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials
Guangyan Mu, Qian Xiang, Shuang Zhou, Zhiyan Liu, Litong Qi, Jie Jiang, Yanjun Gong, Qiufen Xie, Zining Wang, Hanxu Zhang, Yong Huo, Yimin Cui
Topics & Concepts
MedicinePCSK9AlirocumabEvolocumabAdverse effectInternal medicineMonoclonal antibodyRandomized controlled trialMeta-analysisMonoclonalClinical trialPharmacologyAntibodyImmunologyCholesterolLipoproteinLDL receptorApolipoprotein A1Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular DiseasesCeliac Disease Research and Management